article thumbnail

NCIA Event, June 13: Paul Coble Moderates Panel on Testing and Labeling for “Minor Cannabinoid” Products

Canna Law Blog

We are pleased to announce Paul Coble as a panelist moderator for the National Cannabis Industry Association (NCIA) webinar event this coming Tuesday, Jun 13, 2023 at 12:00 PM. The event is titled, From Lab to Label: Safegaurding Consumers in the Cannabinoid Product Landscape.

Events 72
article thumbnail

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

Cannabis Law Report

Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws.

Data 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Psymposia Report: MAPS Canada’s Data Breach Foreshadows Corporadelic Future

Cannabis Law Report

You are receiving this communication, as I believe you’re interested in events in the psychedelic community,” the email reads. “I I intend to periodically send out information about events, publications and news stories that are relevant to those who are interested in our global process of turning psychedelics into medicines.

Data 52
article thumbnail

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Leadership & Product Launch Event in Prague

Cannabis Law Report

(OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® will host its Europe Regional Event in Prague on March 5 and 6, 2022. CEO Blake Schroeder.

Events 52
article thumbnail

Realm of Caring Appoints Research Director to Oversee Groundbreaking Cannabis Data Registry and Medical Studies

Cannabis Law Report

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior.

Data 105
article thumbnail

High-Potency THC Concentrates Are Just As Safe As Regular-Potency Weed, More Data Shows

SpeedWeed

All across the US, lawmakers are scrambling to pass laws that would cap the strength of high-potency cannabis concentrates, arguing that high THC levels pose a serious health risk. The researchers also found that pot did not impair subjects’ ability to remember the sequence of previous events. View original article.

article thumbnail

Data Domain: Analyzing Cannabis Sales and Marketing Trends through Business Insights

Cannabis Law Report

BONG SCORE We apply our entirely subjective bong score to each event 1 Don’t Bother Unless You Need A… Read More.

Data 93